Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$8.18 - $23.98 $76,458 - $224,141
-9,347 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$15.81 - $29.0 $51,429 - $94,337
-3,253 Reduced 25.82%
9,347 $206,000
Q3 2020

Nov 16, 2020

BUY
$18.75 - $28.58 $93,750 - $142,900
5,000 Added 65.79%
12,600 $256,000
Q2 2020

Aug 14, 2020

BUY
$15.6 - $54.87 $118,560 - $417,012
7,600 New
7,600 $210,000

Others Institutions Holding IMRA

About IMARA Inc.


  • Ticker IMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,287,300
  • Market Cap $552M
  • Description
  • IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...
More about IMRA
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.